The world is changing fast and to keep up you need local knowledge with global context.
BizNews Health covers cutting-edge research, advances, opinions and debates in medicine, health and wellbeing from orthodox, complementary and alternative perspectives. We have a special focus on nutrition, fitness, longevity medicine, and prevention of non-communicable diseases – such as obesity, cancer, type 2 diabetes, heart disease and stroke, increasingly mood disorders such as depression, and dementias. We include lifestyle and travel to healthy destinations, since mind and body are integrally connected, and optimum health is not just the absence of disease, but a state of complete physical, mental, and even spiritual wellbeing.
Dr Duncan Carmichael decided to write this article on Covid-19 vaccination in response to many of his patients asking him whether or not they should get the jab.
This article, written by eleven doctors and professors to the Department of Health, urges the Department to facilitate the use of Ivermectin in the public health sector.
UKZN Professor Colleen Aldous talks to Alec Hogg on a controversial topic that has divided opinions for many months now – Ivermectin.
“Soon-Shiong said he wants to develop vaccine production capacity for mRNA shots and adenovirus-based inoculations like ImmunityBio’s in SA.”
Professor Colleen Aldous argues that trusting experts who advocate against ivermectin is being done at the potential cost of human life.
Shionogi has started human trials for a once-a-day pill designed to neutralise Covid-19 in less than a week, reports The Wall Street Journal.
As daily covid deaths in Sweden hits zero, the unusual strategy adopted by the country appears to have been the best approach to the pandemic.
Marc Girardot of PANDA discusses the power of natural immunity in respect of children and those who have recovered from Covid-19.
A record 257 492 Covid-19 shots were administered on Wednesday 21, adding to the ever-increasing total of just over 5.8 million vaccinations.
“The study examined only one aspect of protection, J&J said, and didn’t consider long-lasting responses among immune cells stimulated by its vaccine.”